James Graham: CEO of Recce Pharmaceuticals

Portrait of James Graham

James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs.

Steinway Annual Report cover detail
Steinway Musical Instruments

Extending Our Reach

Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom

Notable employee working in the lab.
Notable

Delivering the Right Drug to the Right Patient